MKMerel L. Kimman

Merel L. Kimman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Merel L. Kimman has a total of 259 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of a Core Outcome Set for Inflammatory Bowel Disease With Irritable Bowel Syndrome‐Like Symptoms for Use in Clinical Trials and Clinical Practice: A Study Protocol

    by Yu Fan Chen, Ilse van de Koppel, Marieke J. Pierik, Daniel Keszthelyi, Luisa Avedano, Roberto Saldaña, Menne Scherpenzeel, Jean‐Frederic Colombel, Merel L. Kimman, Zlatan Mujagić

    Background: Up to one‐third of patients with inflammatory bowel disease (IBD) in remission experience residual symptoms including irritable bowel syndrome (IBS)‐like symptoms, which impair quality of life and psychological well‐being. Evidence supporting therapeutic interventions remains limited. Furthermore, considerable heterogeneity in definitions of residual symptoms and reported outcomes hampers comparison between studies and limits translation into clinical practice and guidelines. We therefore aim to develop an international core outcome set (COS) for residual symptoms in patients with IBD in remission including IBS‐like symptoms for use in clinical trials and routine care. Methods: The COS will be developed in accordance with the Core Outcome Measures in Effectiveness Trials (COMET) Handbook. Potential residual symptoms and outcomes will be identified through qualitative patient interviews and a systematic review of the literature and categorised according to the COMET taxonomy. Identified outcomes will subsequently be prioritised through an international Delphi consensus exercise of up to three rounds involving patients and healthcare professionals (e.g., gastroenterologists, IBD nurse specialists/physician assistants, dieticians, psychiatrists). Finally, a consensus meeting with representatives from all stakeholder groups will be held to discuss and vote on the final COS. Discussion: The development of a COS for IBD with residual symptoms including IBS‐like symptoms will improve consistency of outcome measurement and reporting, facilitate comparability and synthesis of evidence and ensure that relevant outcomes for both patients and healthcare professionals are measured. Trial Registration: The study is registered in the COMET database ( https://www.comet‐initiative.org/Studies/Details/4119 )

  • Open Access

    Determining core quality of life outcomes for patients with vulvar cancer and their partners: a Delphi consensus study

    by Astrid Machielsen, Nikki Meijer, Jessy van Dongen, Dorry Boll, Emiel van Haren, Maaike Oonk, Johanna Annemijn W. M. Aarts, Simone Oerlemans, Merel Kimman, Edith van Esch, et al.

    Purpose: This study aimed to develop a patient-centered and partner-centered core outcome set (COS) reflecting the health-related quality of life (HRQoL) outcomes most important to patients with vulvar cancer following surgical treatment and their partners. Identifying these outcomes enables healthcare professionals to better support patients’ HRQoL during and after treatment. Methods: A mixed-methods study conducted in the Netherlands from December 2021 to March 2024 among patients with vulvar cancer, their partners, and healthcare professionals involved in their care. The study followed a three-step approach: (1) a literature review to identify HRQoL concepts and existing questionnaires; (2) interviews with patients, partners, and healthcare professionals to extract important outcomes; and (3) an online Delphi study, followed by an online consensus meeting, to prioritize outcomes. The primary outcomes were the development of patient-centered and partner-centered COS and the identification of validated questionnaires for HRQoL assessment. Results: The patient-centered COS comprised 45 outcomes in the domains of physiological functioning, including physical symptoms, as well as physical, sexual, and emotional functioning. The COS also included topics that are less often included in studies, i.e., wound healing, body image, and fear of recurrence. The partner-centered COS included six outcomes only focusing on information provision, not on their own HRQoL. Recommended patient HRQoL questionnaires were (scales from) EORTC QLQ-C30/VU34/SH22/INFO25 and WOUND-Q. Conclusions: This is the first patient-centered COS for vulvar cancer, enabling targeted HRQoL assessments and improved daily clinical care. The provision of information was the only aspect deemed important as an outcome for partners.

  • Open Access

    Patient-based evidence in mechanism-based drug repurposing: Challenges and recommendations

    by Merel Kimman, Manuela Joore, Sabine Grimm

  • Open Access

    Evaluating negative pressure wound therapy in breast conserving surgery - a two-arm interventional study

    by Nick Servaas, Merel A. Spiekerman van Weezelenburg, Aike Bruijsten, Loeki Aldenhoven, Sander van Kuijk, Merel Kimman, Elisabeth R.M. van Haaren, Alfred Janssen, Rikki Verdonck, Yvonne L.J. Vissers, et al.

    Introduction:Breast conserving surgery (BCS) is the preferred surgical approach for breast cancer. The most common postoperative complications following BCS are surgical site infection, wound dehiscence, abscess, hematoma and seroma formation. Negative Pressure Wound Therapy (NPWT) has been proven to reduce complications after a broad range of surgical procedures. This study aims to identify the effect of NPWT on wound complications after BCS without level 2 or higher oncoplastic reconstruction.Methods:This single-centre two-arm interventional study compared NPWT with standard wound dressing (SWD) after BCS. A prospective NPWT-cohort was compared to a retrospective SWD-cohort. The follow-up was three months. The primary outcome was the incidence of complications requiring intervention. Secondary outcomes were wound complications, reinterventions, NPWT-compliance, unplanned visits and pain.Results:In total, 293 patients who underwent BCS were included: 150 received NPWT and 143 received SWD. NPWT significantly reduced wound complications requiring intervention compared to SWD (2.7% vs. 11%, p=0.007) and overall wound complications (25% vs. 36%, p=0.040). Seroma and hematoma formation were the most frequent complications, with seroma being significantly less common in the NPWT-group (p=0.045). NPWT was tolerated well by patients, with 85% of patients completing treatment and reporting low pain scores (median NRS 1 [IQR 0–2]). NPWT-use lowered the odds of exerting wound complications requiring an intervention by 3.4 times when corrected for confounders.Conclusions:NPWT following BCS is associated with a significant reduction in postoperative wound complications requiring an intervention. NPWT was well tolerated, with high compliance and minimal pain, without increasing the burden of outpatient follow-up.

  • Open Access

    The Burden of Small Fiber Neuropathy: Changes in Pain, Costs, and Quality of Life Before and After Diagnosis

    by Dennis Kool, Margot Geerts, Lloyd Brandts, Merel Kimman, Caroline M. L. Gorissen‐Brouwers, Catharina G. Faber, Ingemar S. J. Merkies, Janneke G. J. Hoeijmakers

    Background and Aims: Small fiber neuropathy ( SFN ) is a peripheral neuropathy causing neuropathic pain, reduced quality of life ( QoL ), and high societal costs. Previous studies assessed these societal costs before a definitive diagnosis was established, leaving it unclear whether diagnostic confirmation affects costs, pain intensity, or QoL . This study assessed changes in these outcomes before and after diagnosis. Methods: Patients referred to the tertiary SFN expertise center in the Netherlands completed questionnaires before diagnosis (at placement on the waiting list, approximately 7 months before consultation) and at 3 and/or 6 months after confirmation. Healthcare utilization, patient and family costs, and productivity losses were assessed using the iMTA Medical Consumption and Productivity Cost Questionnaires. QoL was measured with the EQ‐5D‐5L and pain intensity with a numeric rating scale. Missing data were handled using multiple imputation, and changes over time were analyzed using within‐subject comparisons and generalized linear mixed models. Results: Eighty‐four patients completed both pre‐ and postdiagnosis questionnaires. After follow‐up, total healthcare costs, patient and family costs, productivity losses, pain intensity, and QoL remained unchanged. However, diagnostic confirmation of SFN was associated with fewer medical specialist visits, lower related costs, and improved health perception. Interpretation: These findings suggest that diagnostic clarification alone is insufficient to reduce the overall burden of SFN, highlighting the need for more effective symptom management and supportive care strategies.

  • Open Access

    Unmet care needs in Hailey–Hailey disease ( ATP2C1 nonsyndromic epidermal differentiation disorder): a qualitative interview study

    by Marie-Eline P H Debeuf, Fauve C A P van Veen, Diede Spätjens, Merel L Kimman, Michel van Geel, Peter M Steijlen, Antoni H Gostynski, Valerie L R M Verstraeten

    This qualitative study provides in-depth insight regarding the disease burden associated with Hailey–Hailey disease (recently renamed ATP2C1-nEDD) and the unmet care needs faced by patients and healthcare professionals. Future research should focus on tackling these needs and increasing knowledge and awareness of Hailey–Hailey disease. A consensus-based guideline should also be developed in order to provide tailor-made medical care.

  • Open Access

    Comparison of Quality of Life Between Patients with Chronic Unilateral Vestibular Hypofunction and Bilateral Vestibulopathy

    by Mustafa Karabulut, Wolfgang Viechtbauer, Lisa Van Stiphout, Merel Kimman, Vincent Van Rompaey, Alfarghal Mohamad, Nils Guinand, Angélica Perez Fornos, Raymond Van de Berg

    BACKGROUND: To compare symptom burden, functional impact, emotional well-being, and health-related quality of life (HRQoL) between patients with chronic unilateral vestibular hypofunction (UVH) and bilateral vestibulopathy (BVP). METHODS: This cross-sectional study included 100 patients with chronic UVH and 148 patients with BVP from a tertiary referral center. Symptom burden and functional impact were assessed using the Bilateral Vestibulopathy Questionnaire, Dizziness Handicap Inventory, and Oscillopsia Severity Questionnaire (OSQ). Emotional well-being was evaluated with the Hospital Anxiety and Depression Scale, and HRQoL with the EuroQol 5-Dimension 5-Level and Health Utility Index Mark 3. Total scores were compared across groups. Standardized mean differences (SMDs) were calculated to quantify the differences across all patient-reported outcome measures. RESULTS: Bilateral vestibulopathy patients reported significantly greater symptom burden and functional limitations than chronic UVH patients (P < .05). No significant group differences were found in emotional well-being or generic HRQoL. Both patient groups showed significantly worse outcomes than healthy controls across most domains (P < .05). Standardized mean difference analysis showed that when effect sizes between groups were large or moderate, the differences were statistically significant. Conversely, when effect sizes were very low or small, there were no statistically significant differences (except for the OSQ, which remained significant despite a small effect size). CONCLUSION: Chronic UVH and BVP are associated with significantly reduced QoL. Bilateral vestibulopathy patients report a greater symptom burden and functional limitations compared to patients with chronic UVH. These findings demonstrate the need for tailored assessments and targeted rehabilitation strategies for vestibular patients.


  • Open Access

    Integrating Environmental Aspects into Health Technology Assessment: A Qualitative Study among Dutch Stakeholders

    by Rhiannon C. Reising, Mohamed El Alili, Merel L. Kimman, Mickael Hiligsmann

    Background: The Dutch National Health Care Institute (ZIN) advises the Dutch Minister of Health on the basic benefit package using Health Technology Assessment (HTA), focusing on necessity, clinical effectiveness, cost-effectiveness, and feasibility. Despite the huge environmental impact of the healthcare sector, this impact is not taken into consideration. Several methodological approaches to integrate the environmental impact into HTA have been proposed, including information conduit, integrated evaluation, parallel evaluation, and environment-focused evaluation. There is significant uncertainty as to which approach is the most appropriate. Therefore, it is important to understand stakeholders’ perspectives on these approaches. Objectives: To explore Dutch stakeholders’ perspectives on integrating environmental impacts into HTA and assess preferred methods and challenges. Methods: A qualitative study using a focus group with members from ZIN (n = 7) and individual interviews (n = 7) with experts in HTA, market access, and reimbursement. Interviews were transcribed and analyzed thematically. Results: Stakeholders highlighted the importance of addressing environmental impacts such as pharmaceutical pollution, greenhouse gas emissions, and waste. Integrated and parallel evaluations were preferred, but barriers such as data gaps, methodological complexity, and lack of guidelines were noted. Conclusion: Incorporating environmental impacts into HTA is crucial but requires clear guidelines, better data, and stakeholder collaboration to support sustainable healthcare practices.


  • Open Access

    Cost analysis of four surgical techniques for pediatric inguinal hernia repair in a Dutch hospital

    by Roxanne Eurlings, Merel L. Kimman, Lloyd Brandts, Ruben G.J. Visschers, Wim G. van Gemert